SYNARC to Host Webinar on Atherosclerotic Plaque in January 2012

Newark, CA – November 28, 2011 – SYNARC, the world's leading provider of medical imaging services for the pharmaceutical, biotechnology, and medical device industries, announced today that the third in our series of complimentary educational webinars will be conducted on Invasive Assessment of Atherosclerotic Plaque. The webinar will be presented on Tuesday, January 24th at 12PM – 1:30PM EST (9AM – 10:30AM PST). Our complimentary series is designed to help participants better understand the benefits of using imaging for clinical trials and will cover a range of topics and therapeutic areas.

The webinar will be presented by Gary S. Mintz, M.D., Chief Medical Officer of the Cardiovascular Research Foundation, Editor-in-Chief of TCTMD.com, and a Co-Director of Transcatheter Cardiovascular Therapeutics (TCT). Dr. Mintz has extensive experience in both interventional cardiology and cardiac ultrasound and is an expert in the area of cardiovascular imaging. He joined the Cardiovascular Research Foundation in 1991 as Director of the Coronary Ultrasound Program, which has studied over 30,000 patients using intravascular ultrasound and has made fundamental observations about the pathology, pathogenesis, and mechanisms of coronary atherosclerosis, catheter-based interventions, and restenosis.

He is the author of over 675 articles, 50 book chapters, and 625 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and intravascular ultrasound.In 2005, Dr. Mintz published the single-authored textbook Intracoronary Ultrasound, the definitive work in the field.

About SYNARC

SYNARC has extensive expertise in cardiovascular imaging services including angiography, echocardiography, cardiac MRI, carotid intima media thickness (CIMT), intravascular ultrasound (IVUS) and other modalities to support cardiovascular clinical programs, as well as cardiac safety assessments in other therapeutic areas such as oncology and metabolic diseases. SYNARC continues to build its cardiovascular franchise and in particular, to broaden the range of imaging modalities it offers its clients for use in clinical trials.

Media Contact:
Sahar Waziri
+1 415 817-7949
sahar.waziri@synarc.com